Glenmark Reaps Favipiravir Gains, Progresses COVID-19 Nasal Spray
Emergency India Go-Ahead For NO Spray?
Strong run on Indian market for Glenmark in fiscal Q1, with the company optimistic of prospects for new introductions including generic Brovana in the US, where it expects close to double-digit growth in Q2. All eyes are also on the launch timelines of a partnered nitric oxide nasal spray for COVID-19.
